Don C Laird

Title: Don C. Laird: Innovator in Molecular Biology

Introduction: Don C. Laird, an accomplished inventor based in Mundelein, Illinois, has made significant contributions to the field of molecular biology. With a focus on innovative antibody therapies, Laird has secured a patent that addresses important therapeutic needs in medical science.

Latest Patents: Laird holds a patent for a soluble FMS-like tyrosine kinase-1 (sFLT-1) antibody and its related compositions, kits, methods of use, and materials for making. This invention features an isolated antibody specifically designed to bind to sFlt-1 or its fragments, which plays a crucial role in various biological processes. The patent also includes a pharmaceutical composition and a method to determine the presence and concentration of sFlt-1 in test samples. Additionally, it outlines techniques for treating patients requiring an antagonist of sFlt-1, as well as components such as isolated nucleic acids encoding relevant amino acid sequences.

Career Highlights: Laird is affiliated with Abbott Laboratories Corporation, a leader in healthcare solutions. His work at Abbott has allowed him to apply his expertise in biotechnology and therapeutic innovations, paving the way for advancements in medical treatments and diagnostics.

Collaborations: Throughout his career, Laird has collaborated with esteemed colleagues including Susan E. Brophy and Saul A. Datwyler. These partnerships have enriched his research endeavors and contributed to the successful development of his patented technologies.

Conclusion: Don C. Laird exemplifies the spirit of innovation in the field of biotechnology. His patented work on the sFLT-1 antibody signifies a vital step forward in understanding and treating medical conditions influenced by this target. Laird's contributions, alongside his collaborative efforts with fellow researchers, continue to highlight the importance of scientific inquiry and development in healthcare solutions.